Enter your login e-mail to the account
Search
Search parameters
Search results
- Současnost a perspektivy léčby dyslipidémií
doc. MUDr. Jan Bultas, CSc., MUDr. Debora Karetová
(1/2004, Main topic ) - Prehľad – články publikované v časopise Via practica v roku 2010 (7. ročník)
red
(1/2011, Electronic attachment ) - Rosuvastatín: nový inhibítor 3-hydroxy-3-methylglutaryl koenzým a reduktázy
doc. MUDr. Martin Gajdoš,CSc., MUDr. Ľubica Cibulová, RNDr. Zora Krivošíková, PhD.,
(1/2004, Medicine ) - Chyby a úskalí terapie statiny
MUDr. Lubor Goláň
(1/2004, Main topic ) - SECONDARY PREVENTION IN ACUTE MYOCARDIAL INFARCTION
MUDr. Branislav Tomašovič, MUDr. Marián Kozlovský
(1/2006, Topic ) - The main points of the new guidelines for management of acute myocardial infarction with ST-segment elevation – STEMI
prof. MUDr. Vasiľ Hricák, CSc., FESC
(5/2013, Review articles ) - Evolokumab pro léčbu familiární hypercholesterolémie
prof. MUDr. Vladimír Bláha, CSc.
(4/2018, Drugs & drug classes ) - The Importance of Omega – 3 Fatty Acids in the Treatment of Dyslipidemia
prof. MUDr. Daniel Pella, PhD.
(12/2009, Topic of the year ) - Komentár k odporúčaniam ACC/AHA (ACC/AHA Guidelines on the Treatment of Blood Cholesterol)
MUDr. Ľubomíra Fábryová, PhD., prof. MUDr. Andrej Dukát, CSc., FESC
(2/2014, Information & comments ) - Future of hypolipidemic therapy
MUDr. Fábryová Ľubomíra, PhD.
(5/2010, Topic of the year ) - Combined hypolipidemic therapy in current clinical practice
MUDr. Ľubomíra Fábryová, PhD.
(6/2014, Review articles ) - CLIMACTERIC AND THE CARDIOVASCULAR SYSTEM
MUDr. Ján Števlík
(6/2006, Main topic ) - NOVÉ TRENDY V PREVENCII ATEROSKLERÓZY
(3/2007, Events ) - WHAT IS THE POSITION OF STATINS IN THE TREATMENT OF PATIENTS WITH HEART FAILURE?
prof. MUDr. Andrej Dukát, CSc., FESC, doc. MUDr. Ľudovít Gašpar, CSc.,, doc. MUDr. Jana Sirotiaková, CSc., MUDr. Peter Minárik
(9/2006, Main topic ) - Pharmacological therapy and non-pharmacological measures in patient after myocardial infarction
prof. MUDr. Peter Mitro, PhD.
(2/2011, Review articles ) - Overview of pharmacotherapy of atrial fibrillation (update for general practitioners)
doc. MUDr. Ján Kmec, PhD.
(5/2012, Review articles ) - Promoting prevention and treatment of cardiovascular disease through nutrition supplements
doc. MUDr. Štefan Farský, CSc., FESC
(5/2012, Review articles ) - HYPOLIPIDEMIKÁ V REÁLNEJ PRAXI A V PERSPEKTÍVE
prof. MUDr. Milan Kriška, DrSc.
(10/2007, clearly ) - MANAGEMENT OF ATHEROGENIC DYSLIPIDAEMIA IN THE METABOLIC SYNDROME
MUDr. Ľubomíra Fábryová
(S4/2007, Supplement ) - METABOLIC SYNDROME, CARDIOVASCULAR AND METABOLIC RISK
prof. MUDr. Peter Galajda, CSc.
(S4/2007, Supplement ) - Pharmacotherapy of chronic forms of ischemic limb disease according to current guidelines
MUDr. Jiří Holý, MUDr. Martin Holý, MUDr. Zsolt Keczkemethy, MUDr. Kamila Nováková, MUDr. Pavel Havránek
(3/2012, Review articles ) - Pán doktor, príďte! Zápisky lekára po 100 rokoch
MUDr. Jozef Jakuš
(4/2005, Relax ) - XV. medzinárodné sympózium – Drugs Affecting Lipid Metabolism – DALM
MUDr. Ľubomíra Fábryová
(1/2005, Spectrum ) - POSSIBILITIES OF DIAGNOSIS AND TREATMENT OF LIPIDS DISORDERS IN AMBULANCE OF GENERAL PRACTITIONER
MUDr. Ľubomíra Fábryová
(6/2005, clearly ) - Hypolipidemic treatment of patients with nonalcoholic fatty liver disease
doc. MUDr. Peter Jarčuška, PhD., MUDr. Martin Janičko, MUDr. Eduard Veseliny, MUDr. Ján Fedačko, MUDr. Božena Nováková, prof. MUDr. Daniel Pella, CSc.
(6/2010, Topic of the year ) - Significance of combined hypolipidemic therapy for patients with metabolic syndrome
MUDr. Renáta Palmajová
(3/2010, Original articles & case reports ) - Muscle cramps in general practice
doc. MUDr. Peter Špalek, PhD.
(6/2010, Interdisciplinary consilium ) - STATINS – DO THEY HAVE DOMINANT POSITION IN CARDIOVASCULAR PREVENTION? LIPID LOWERING AND PLEIOTROPIC EFFECTS OF STATINS
doc. MUDr. Daniel Pella, PhD., MUDr. Viola Vargová, PhD., MUDr. Ján Fedačko, MUDr. Richard Raši
(1/2007, clearly ) - LONGTERM CARE AFTER ACUTE CORONARY SYNDROME WITHOUT ELEVATION OF ST-SEGMENT IN PRACTITIONER`S OFFICE
MUDr. Eva Baranová
(5/2007, Topic ) - IMMUNOMODULATORY EFFECTS OF STATINS
doc. MUDr. František Gazdík, PhD.
(5/2007, clearly ) - MANAGING DYSLIPIDAEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE
MUDr. Ľubomíra Fábryová
(10/2005, Topic ) - Ezetimibe in the treatment of hypercholesterolaemia
doc. MUDr. David Karásek, Ph.D.
(3/2020, Review articles ) - PREVENTION OF THE ISCHEMIC HEART DISEASE
MUDr. Milan Luknár, MUDr. Branislav Líška
(4/2005, Topic ) - Care for patients after myocardial revascularization therapy in general practitioner`s office
Prof. MUDr. Vasiľ Hricák, PhD., FESC
(6/2016, Review articles ) - Epidemiology and health consequences of obesity
MUDr. Ľubomíra Fábryová, PhD.
(1/2015, Topic of the year ) - Statins and acute coronary syndrome
prof. MUDr. Ján Murín, CSc.
(1/2010, Review articles ) - Molecular genetics of dyslipidemy
Ing. Jaroslav A. Hubáček, CSc., MUDr. Michal Vrablík, PhD.
(4/2009, Topic of the year ) - Role of niacin in a hypolipidaemic treatment in high cardiovascular risk patients
prof. MUDr. Andrej Dukát, CSc., doc. MUDr. Ľudovít Gašpar, CSc., MUDr. Peter Minárik, doc. MUDr. Martin Wawruch, PhD., doc. MUDr. Stanislav Oravec, CSc., MUDr. Peter Sabaka
(1/2010, Topic of the year ) - Drug-induced myopathy with cholesterol-lowering and triacylglycerol-lowering agents
doc. MUDr. Peter Špalek, CSc., MUDr. Denis Richter
(1/2010, Interdisciplinary consilium ) - Srovnání účinnosti semi-generického a originálního atorvastatinu
doc. MUDr. Richard Češka, CSc., prof. MUDr. Helena Vaverková, CSc., as. MUDr. Michal Vrablík, PhD., Jitka Housová, Tomáš Štulc, Željko Reiner, Zvonimir Rumboldt
(5/2005, Spectrum ) - Combined hypolipidemic therapy using statins and fibrates reducing the cardiovascular risk in the patients with atherogenic dyslipidemia
prof. MUDr. Vladimír Bláha, CSc.
(4/2010, Topic of the year ) - New options in diagnostics and treatment of familial hypercholesterolemia
MUDr. Šárka Tesařová, Prof. MUDr. Michal Vrablík, Ph.D.
(3/2019, Review articles ) - XIV. medzinárodné sympózium o ateroskleróze v Ríme
MUDr. Ľubomíra Fábryová
(9/2006, Events ) - Poškodenie pečene alkoholom a liekmi
doc. MUDr. Peter Jarčuška, PhD., MUDr. Mária Zakuciová, MUDr. Eduard Veseliny
(10/2006, clearly ) - Safety treatment with statins
prof. MUDr. RNDr. Rudolf Pullmann, PhD.
(1/2014, Review articles ) - CONGESTIVE HEART FAILURE TREATMENT
prof. MUDr. Viliam Bada, CSc.
(11/2007, Topic ) - Statins and ezetimibe – current position in the treatment of dyslipidaemias (cardiovascular prevention)
doc. MUDr. Jana Sirotiaková, PhD., RNDr. Miriam Zagyiová
(10/2009, Topic of the year ) - Srdcové zlyhávanie 2016 (HFA/ESC) a 3. svetový kongres o akútnom srdcovom zlyhaní, Florencia, Taliansko, 21. – 24. mája 2016, 1. časť
doc. MUDr. Marian Sninčák, PhD., mim. prof.
(4/2016, Events ) - Z jubilejného piateho ročníka kongresu Medicína pre prax (11. – 12. 9. 2009, Bratislava)
Magdaléna Žiaková, redaktorka
(10/2009, Events ) - TREATMENT OF ARRYTHMIA AND PHARMACOTHERAPY POSSIBILITIES
doc. MUDr. Peter Mitro, PhD.
(11/2007, Topic ) - Classification of dyslipoproteinaemias: Part I – Primary dyslipoproteinaemias
MUDr. Ľubomíra Fábryová, PhD.
(5/2009, Topic of the year ) - Prevencia cievnych mozgových príhod
MUDr. Ivan Gogolák, PhD.
(S4/2008, Supplement ) - MANAGEMENT OF OBESE PATIENTS WITH CARDIOMETABOLIC RISK
doc. MUDr. Boris Krahulec, CSc., MUDr. Dáša Mesárošová
(3/2008, Topic )
- METABOLIC SYNDROME AND SELECTED MENTHAL ILLNESSES
doc. MUDr. Roman Jirák, CSc., doc. MUDr. Miroslav Zeman, CSc.
(4/2008, Review articles ) - Mild cognitive impairment – Do we know more now?
MUDr. František Honzák
(1/2016, Digital publications ) - The antidepressants treatment in patients with high cardiovascular risk: benefit or risk?
MUDr. Radkin Honzák, Milan Vrána
(6/2009, Review articles ) - DEPRESSION, CORONARY ARTERY DISEASE, AND MYOCARDIAL INFARCTION
MUDr. Jiří Podlipný, MUDr. Zdeněk Hess
(4/2006, Review articles )
- New drugs era in treating multiple sclerosis
MUDr. Marta Vachová
(5/2009, Review articles ) - Publikujeme v zahraničí / Zo zahraničnej tlače
(2/2005, Papers from literature ) - Central nervous system vasculitis
MUDr. Aleš Tomek, Ph.D., FESO
(6/2015, Main topic ) - Statins and myopathy
prof. MUDr. Zdeněk Ambler, DrSc. †
(6/2013, Review articles ) - Toxic myopathies
doc. MUDr. Edvard Ehler, CSc. , Prof. MUDr. Josef Zámečník, Ph.D.
(6/2016, Review articles ) - Toxické a lékové myopatie
prof. MUDr. Josef Bednařík, CSc.
(3/2004, Main topic ) - Neurologické projevy poruch metabolizmu lipidů
doc. MUDr. Ivanka Vlachová
(1/2005, Main topic ) - Statins and their influence on peripheral nervous system
doc. MUDr. Edvard Ehler, CSc.
(3/2020, Review articles ) - Ze zahraničního tisku
(4/2004, Papers from literature ) - Doporučená léčba po prodělané cévní mozkové příhodě
doc. MUDr. Zbyněk Kalita, CSc.
(6/2002, Review articles ) - Co dále po prodělaném akutním ischemickém iktu nebo tranzitorní ischemické atace?
doc. MUDr. Zbyněk Kalita, CSc.
(4/2001, Main topic ) - Drug-induced depression
doc. MUDr. Dana Končelíková, Ph.D.
(4/2021, From the boundary of neurology ) - Stroke in diabetic patients
doc. MUDr. Jaromír Chlumský, Ph.D., prof. MUDr. Jindra Perušičová, DrSc., prof. MUDr. Milan Kvapil, CSc.
(1/2010, From the boundary of neurology ) - Zo zahraničnej tlače
(6/2006, Papers from literature ) - Neuromuskulární komplikace farmakoterapie
MUDr. Eva Vlčková, Ph.D. – editorka hlavnej témy
(1/2017, Main topic ) - Effects of drugs on neuromuscular junction
MUDr. Stanislav Voháňka, CSc., MBA
(1/2017, Main topic ) - Statins and neuroprotective effects
prof. MUDr. Ivana Štětkářová, CSc., MHA, FEAN, PharmDr. Aleš Dvořák, MBA
(1/2021, Review articles ) - Statin myopathy
Prof. MUDr. Josef Bednařík, CSc., MUDr. Eva Vlčková, Ph.D., MUDr. Tomáš Horák
(1/2017, Main topic )
- Cancer Drugs Fund – starting point or final solution to pay for innovative oncology treatment?
MUDr. Pavol Adamkov, Ing. Petra Szilágyiová, Mgr. Tomáš Pastorek
(1/2014, Main topic )
- DIABETIC FOOT SYNDROME – A SERIOUS COMPLICATION OF DIABETES MELLITUS
MUDr. Pavlína Piťhová
(3-4/2007, Interdisciplinary overviews ) - Comorbidities in psoriasis – a new perspective of an old disease
doc. MUDr. Vladimír Vašků, CSc.
(3/2009, Review articles )
- HYPOLIPIDEMIKÁ V REÁLNEJ PRAXI A V PERSPEKTÍVE
prof. MUDr. Milan Kriška, DrSc., MUDr. Ján Kriška
(1/2008, Drug classes ) - STATÍNY – MAJÚ DOMINANTNÉ MIESTO V KARDIOVASKULÁRNEJ PREVENCII? LIPIDY ZNIŽUJÚCE A PLEIOTROPNÉ ÚČINKY STATÍNOV
doc. MUDr. Daniel Pella, PhD.
(2/2007, clearly ) - METABOLIC SYNDROME AND SELECTED MENTHAL ILLNESSES
doc. MUDr. Roman Jirák, CSc., doc. MUDr. Miroslav Zeman, CSc.
(4/2008, Review articles ) - MANAGEMENT OF OBESE PATIENTS WITH CARDIOMETABOLIC RISK
doc. MUDr. Boris Krahulec, CSc., MUDr. Dáša Mesárošová
(2/2008, Review articles )
- Active substances in medicinal mushrooms
MUDr. Jana Mrázová
(3/2016, Phytotherapy ) - The topic of medication non-adherence of geriatric patient and its solution during the individual consultation in a community pharmacy
PharmDr. Jana Šolínová, doc. PharmDr. Josef Malý, Ph.D.
(3/2016, Case reports in pharmacy practice ) - Drug-induced depression
doc. MUDr. Dana Končelíková, Ph.D.
(2/2022, Current pharmacotherapy ) - Novel targeted therapeutics in dyslipoproteinemia
PharmDr. Ľubica Lehocká, PhD., PharmDr. Lucia Masaryková, PhD., PharmDr. Anna Oleárová, PhD., MPH, MUDr. Katarína Jurečková
(3-4/2015, Current pharmacotherapy ) - What can statins do in the management of cardiovascular deseases?
MUDr. Marta Filková, prof. MUDr. Ján Murín, CSc.,, MUDr. Miroslav Pernický
(1/2013, Current pharmacotherapy ) - Niacin-laropiprant combination: novel approach not only to treatment of dyslipidemia Complex management of dyslipidemia provides a chance of further reduction of atherosclerotic vascular
MUDr. Michal Vrablík, Ph.D., MUDr. Eva Motyková, prof. MUDr. Richard Češka, CSc.
(1/2011, New medicinal substances ) - Dyslipidémie ako rizikový faktor kardiovaskulárnych ochorení: dôraz na familiárnu hypercholesterolémiu, jej včasnú diagnostiku a terapiu
Doc. PharmDr. Adriana Duriš Adameová, PhD.
(2/2018, Current pharmacotherapy ) - Current Possibilities of Dyslipidema Therapy
doc. RNDr. Magdaléna Fulmeková, CSc., PharmDr. Lucia Masaryková, PharmDr. Ľubica Lehocká, PhD.
(2/2011, Current pharmacotherapy ) - Safety treatment with statins
prof. MUDr. RNDr. Rudolf Pullmann, PhD.
(4/2013, Clinical pharmacy )
- Periférne artériové ochorenie dolných končatín a globálne kardiovaskulárne riziko – možnosti ovplyvnenia v klinickej praxi
MUDr. Denisa Čelovská, PhD., prof. MUDr. Viera Štvrtinová, CSc., MUC. Mária Balgová
(1/2018, Main topic ) - Pharmacological treatment of peripheral arterial disease of lower limbs from a vascular surgeon’s point of view
prof. MUDr. Vladimír Šefránek, PhD.
(3-4/2012, Review articles ) - Abstrakty
(1/2009, Abstracts ) - Carotid endarterectomy versus carotid artery stenting
MUDr. Ján Tomka, PhD., MUDr. Roman Slyško, MUDr. Peter Lofaj, MUDr. Katarína Kanáliková, jr. prof. MUDr. Vladimír Šefránek, PhD.
(2/2010, Main topic ) - Statíny – benefi t len zo znižovania lipidov?
prof. MUDr. Daniel Pella, PhD.
(3/2011, Editorial ) - Current status and perspectives of pharmacotherapy of pulmonary arterial hypertension
MUDr. Pavel Jansa
(3/2011, Review articles ) - Statins and ezetimibe – current position in the treatment of dyslipidaemias (cardiovascular prevention)
doc. MUDr. Jana Sirotiaková, PhD., RNDr. Miriam Zagyiová
(4/2010, Drugs & drug classes ) - Zo VII. angiologického dňa II. internej kliniky LF UK a FNsP
Magdaléna Žiaková, redaktorka
(1/2010, Information & comments ) - Claudicatio intermittens – an important marker of systemic atherosclerosis
prof. MUDr. Viera Štvrtinová, PhD.
(3/2010, Main topic ) - XVII. SLOVENSKÝ KONGRES CIEVNEJ CHIRURGIE s medzinárodnou účasťou
(S1/2013, Supplement )